Olaparib for Pulmonary Arterial Hypertension: a Pilot Clinical Study
Phase of Trial: Phase 0
Latest Information Update: 29 Jan 2019
Price : $35 *
At a glance
- Drugs Olaparib (Primary)
- Indications Pulmonary arterial hypertension
- Focus Therapeutic Use
- Acronyms OPTION-p
- 08 Nov 2018 Status changed from not yet recruiting to recruiting.
- 31 Aug 2018 Biomarkers information updated
- 26 Jul 2018 Planned initiation date changed from 1 Jun 2018 to 1 Jan 2019.